Hoth Therapeutics, Inc. - Common Stock (HOTH)
1.3300
+0.00 (0.00%)
NASDAQ · Last Trade: Sep 4th, 7:25 AM EDT
Via Benzinga · September 2, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · September 2, 2025
Hoth Therapeutics reported strong preclinical efficacy and safety data for HT-KIT, a precision antisense therapy targeting KIT-driven cancers.
Via Benzinga · September 2, 2025
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via Benzinga · August 28, 2025
Unusual volume stocks in Friday's session
Via Chartmill · June 6, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · June 5, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 4, 2025

Via Benzinga · June 4, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 4, 2025
Via Benzinga · April 17, 2025

Via Benzinga · January 8, 2025

Via Benzinga · January 8, 2025

Via Benzinga · January 7, 2025

Hoth Therapeutics' HT-001 shows promising interim Phase 2a trial results, improving skin toxicities in cancer patients without treatment-related adverse effects.
Via Benzinga · January 7, 2025

Via Benzinga · January 7, 2025

Via Benzinga · November 20, 2024

Via Benzinga · October 15, 2024

Via Benzinga · September 6, 2024

Via Benzinga · September 5, 2024

Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
Via InvestorPlace · July 25, 2024